| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha 1-Antitrypsin | 35 | 2020 | 81 | 3.730 |
Why?
|
| Mannosidases | 13 | 2020 | 17 | 3.490 |
Why?
|
| Endoplasmic Reticulum | 23 | 2020 | 208 | 2.990 |
Why?
|
| Glycoproteins | 10 | 2011 | 346 | 1.590 |
Why?
|
| Protein Folding | 17 | 2020 | 214 | 1.480 |
Why?
|
| Golgi Apparatus | 6 | 2020 | 92 | 1.420 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2012 | 359 | 0.960 |
Why?
|
| Proteasome Endopeptidase Complex | 6 | 2010 | 241 | 0.840 |
Why?
|
| Proteins | 2 | 2023 | 1006 | 0.740 |
Why?
|
| Proteostasis | 1 | 2023 | 37 | 0.740 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 9 | 2010 | 44 | 0.700 |
Why?
|
| Protein Transport | 6 | 2020 | 366 | 0.690 |
Why?
|
| Mitosis | 2 | 2012 | 191 | 0.620 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 569 | 0.570 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 2 | 2020 | 22 | 0.540 |
Why?
|
| Serpins | 4 | 2011 | 34 | 0.500 |
Why?
|
| Quality Control | 2 | 2014 | 116 | 0.450 |
Why?
|
| Coat Protein Complex I | 1 | 2013 | 12 | 0.380 |
Why?
|
| Calnexin | 6 | 2003 | 12 | 0.380 |
Why?
|
| HeLa Cells | 5 | 2018 | 686 | 0.380 |
Why?
|
| Membrane Proteins | 6 | 2020 | 1590 | 0.370 |
Why?
|
| Protein Subunits | 1 | 2013 | 157 | 0.370 |
Why?
|
| Acetylglucosamine | 1 | 2012 | 6 | 0.360 |
Why?
|
| Calcium-Binding Proteins | 5 | 2008 | 325 | 0.340 |
Why?
|
| Lysosomes | 5 | 2020 | 268 | 0.340 |
Why?
|
| Liver Diseases | 4 | 2010 | 385 | 0.330 |
Why?
|
| Molecular Sequence Data | 10 | 2014 | 3464 | 0.330 |
Why?
|
| Cell Biology | 1 | 2010 | 4 | 0.320 |
Why?
|
| Carbamazepine | 1 | 2010 | 40 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 587 | 0.320 |
Why?
|
| Proteolysis | 1 | 2011 | 200 | 0.310 |
Why?
|
| Oligosaccharides | 3 | 2000 | 71 | 0.300 |
Why?
|
| Schizosaccharomyces | 1 | 2009 | 62 | 0.300 |
Why?
|
| Glycosylation | 5 | 2012 | 127 | 0.290 |
Why?
|
| Genetic Variation | 7 | 2010 | 1559 | 0.290 |
Why?
|
| Animals | 38 | 2020 | 33912 | 0.290 |
Why?
|
| Protein Binding | 5 | 2020 | 1652 | 0.290 |
Why?
|
| Liver Failure | 1 | 2009 | 99 | 0.280 |
Why?
|
| Cell Line | 10 | 2011 | 2552 | 0.270 |
Why?
|
| Histones | 1 | 2012 | 541 | 0.270 |
Why?
|
| Mice | 28 | 2020 | 18301 | 0.270 |
Why?
|
| Amino Acid Sequence | 6 | 2014 | 2395 | 0.260 |
Why?
|
| Mammals | 1 | 2009 | 253 | 0.260 |
Why?
|
| Liver | 11 | 2014 | 1796 | 0.260 |
Why?
|
| Protein Conformation | 6 | 2010 | 732 | 0.260 |
Why?
|
| Down-Regulation | 1 | 2009 | 645 | 0.250 |
Why?
|
| Polysaccharides | 2 | 2005 | 143 | 0.250 |
Why?
|
| Heat-Shock Proteins | 2 | 2002 | 174 | 0.250 |
Why?
|
| MicroRNAs | 1 | 2013 | 889 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 9 | 2003 | 975 | 0.240 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2013 | 982 | 0.220 |
Why?
|
| Humans | 50 | 2020 | 131163 | 0.210 |
Why?
|
| Transfection | 7 | 2009 | 962 | 0.210 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 650 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2010 | 2833 | 0.200 |
Why?
|
| Liver Neoplasms | 4 | 2013 | 1373 | 0.200 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 903 | 0.190 |
Why?
|
| Multienzyme Complexes | 2 | 2002 | 76 | 0.190 |
Why?
|
| MCF-7 Cells | 2 | 2013 | 209 | 0.190 |
Why?
|
| Liver Neoplasms, Experimental | 7 | 2003 | 65 | 0.190 |
Why?
|
| Acetylcysteine | 1 | 2003 | 79 | 0.190 |
Why?
|
| Cysteine Endopeptidases | 2 | 2002 | 110 | 0.180 |
Why?
|
| Peptide Hydrolases | 1 | 2003 | 131 | 0.180 |
Why?
|
| Carbohydrate Sequence | 4 | 2003 | 19 | 0.180 |
Why?
|
| Uridine Diphosphate Glucose | 2 | 2002 | 2 | 0.180 |
Why?
|
| Asparagine | 2 | 2001 | 22 | 0.170 |
Why?
|
| Molecular Chaperones | 3 | 2005 | 172 | 0.170 |
Why?
|
| Glucosyltransferases | 2 | 2002 | 44 | 0.170 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 189 | 0.170 |
Why?
|
| Cells, Cultured | 7 | 2014 | 2885 | 0.160 |
Why?
|
| Biocatalysis | 1 | 2020 | 38 | 0.160 |
Why?
|
| Genes | 5 | 1988 | 308 | 0.160 |
Why?
|
| Protein Domains | 1 | 2020 | 252 | 0.150 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 195 | 0.150 |
Why?
|
| Protein Stability | 1 | 2019 | 165 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 107 | 0.140 |
Why?
|
| Peptide Fragments | 3 | 2012 | 687 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2020 | 801 | 0.130 |
Why?
|
| DNA | 2 | 2023 | 1399 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 716 | 0.130 |
Why?
|
| Base Sequence | 6 | 2014 | 2730 | 0.130 |
Why?
|
| RNA Interference | 1 | 2019 | 491 | 0.130 |
Why?
|
| Carrier Proteins | 3 | 2002 | 993 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2019 | 1571 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 3748 | 0.110 |
Why?
|
| Mice, Transgenic | 6 | 2010 | 2326 | 0.110 |
Why?
|
| Mutation | 9 | 2018 | 6099 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2003 | 573 | 0.110 |
Why?
|
| Neoplasms | 1 | 2009 | 3016 | 0.110 |
Why?
|
| Galactosidases | 3 | 1983 | 7 | 0.110 |
Why?
|
| alpha-Galactosidase | 3 | 1983 | 20 | 0.110 |
Why?
|
| Fabry Disease | 3 | 1983 | 18 | 0.100 |
Why?
|
| Models, Chemical | 2 | 2005 | 78 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 83 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 128 | 0.100 |
Why?
|
| COP-Coated Vesicles | 1 | 2013 | 4 | 0.100 |
Why?
|
| DNA Primers | 1 | 2014 | 599 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 623 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1075 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 135 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 300 | 0.090 |
Why?
|
| G2 Phase | 1 | 2012 | 39 | 0.090 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1992 | 25 | 0.090 |
Why?
|
| Threonine | 1 | 2012 | 62 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 318 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 405 | 0.090 |
Why?
|
| Cricetulus | 1 | 2011 | 90 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 60 | 0.080 |
Why?
|
| Solubility | 1 | 2011 | 117 | 0.080 |
Why?
|
| Binding Sites | 2 | 2011 | 1133 | 0.080 |
Why?
|
| Cricetinae | 1 | 2011 | 362 | 0.080 |
Why?
|
| Peptides | 2 | 2010 | 708 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1990 | 49 | 0.080 |
Why?
|
| Gaucher Disease | 1 | 2010 | 11 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 111 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2009 | 23 | 0.080 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 2 | 2020 | 13 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 1990 | 780 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2010 | 4686 | 0.070 |
Why?
|
| Phenotype | 5 | 2013 | 4497 | 0.070 |
Why?
|
| Enzyme Stability | 1 | 2009 | 58 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 978 | 0.070 |
Why?
|
| Forecasting | 1 | 2010 | 351 | 0.070 |
Why?
|
| Cytosol | 2 | 2006 | 135 | 0.070 |
Why?
|
| Integrin alpha5beta1 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Rabbits | 2 | 2006 | 575 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 378 | 0.070 |
Why?
|
| Age of Onset | 1 | 2009 | 592 | 0.070 |
Why?
|
| Genome | 1 | 2010 | 451 | 0.070 |
Why?
|
| Kinetics | 2 | 2005 | 1088 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2008 | 308 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2010 | 2550 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 232 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 1989 | 2323 | 0.060 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2006 | 15 | 0.060 |
Why?
|
| Autophagy | 1 | 2010 | 417 | 0.060 |
Why?
|
| RNA | 1 | 2010 | 517 | 0.060 |
Why?
|
| Neuropeptides | 2 | 2007 | 106 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2007 | 552 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2465 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3819 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 2026 | 0.060 |
Why?
|
| alpha-Mannosidase | 1 | 2004 | 1 | 0.050 |
Why?
|
| 1-Deoxynojirimycin | 2 | 1997 | 2 | 0.050 |
Why?
|
| Gene Expression | 2 | 2004 | 1481 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1371 | 0.050 |
Why?
|
| Endoplasmic Reticulum, Smooth | 1 | 2003 | 1 | 0.050 |
Why?
|
| Glucose | 2 | 1999 | 853 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2003 | 35 | 0.050 |
Why?
|
| Transferrin | 1 | 2003 | 46 | 0.050 |
Why?
|
| Mannans | 1 | 2003 | 15 | 0.050 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2003 | 30 | 0.050 |
Why?
|
| Exocytosis | 1 | 2003 | 65 | 0.050 |
Why?
|
| Albumins | 1 | 2003 | 87 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2003 | 287 | 0.050 |
Why?
|
| Leukotriene D4 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Dipeptidases | 1 | 2002 | 15 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2002 | 44 | 0.050 |
Why?
|
| Alkaloids | 1 | 2002 | 37 | 0.050 |
Why?
|
| Endothelium | 1 | 2002 | 59 | 0.050 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2002 | 38 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 1319 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2002 | 101 | 0.040 |
Why?
|
| Genomics | 1 | 2010 | 1621 | 0.040 |
Why?
|
| Calreticulin | 1 | 2001 | 23 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 56 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 423 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 688 | 0.040 |
Why?
|
| Vanadates | 1 | 2000 | 9 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 2000 | 12 | 0.040 |
Why?
|
| Sodium Fluoride | 1 | 2000 | 7 | 0.040 |
Why?
|
| Arsenicals | 1 | 2000 | 17 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2000 | 72 | 0.040 |
Why?
|
| Molecular Biology | 2 | 1992 | 66 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1990 | 252 | 0.040 |
Why?
|
| DNA, Recombinant | 2 | 1990 | 71 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2000 | 1013 | 0.040 |
Why?
|
| Hydrolysis | 1 | 1999 | 141 | 0.040 |
Why?
|
| Codon | 2 | 1989 | 93 | 0.040 |
Why?
|
| Genes, Regulator | 2 | 1989 | 44 | 0.040 |
Why?
|
| alpha 1-Antichymotrypsin | 2 | 2007 | 4 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 1990 | 892 | 0.030 |
Why?
|
| Pulmonary Emphysema | 2 | 1989 | 96 | 0.030 |
Why?
|
| Fibroblasts | 4 | 2008 | 849 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 266 | 0.030 |
Why?
|
| Dementia | 1 | 2002 | 436 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 316 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1989 | 305 | 0.030 |
Why?
|
| Male | 7 | 2019 | 64957 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 767 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2000 | 388 | 0.030 |
Why?
|
| Prenatal Diagnosis | 2 | 1992 | 612 | 0.030 |
Why?
|
| Mitochondria | 1 | 2000 | 785 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 750 | 0.030 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 1992 | 358 | 0.030 |
Why?
|
| Immune Sera | 1 | 1994 | 54 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1994 | 109 | 0.030 |
Why?
|
| Adult | 5 | 2009 | 31282 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1994 | 52 | 0.030 |
Why?
|
| Infant | 1 | 2009 | 13352 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 224 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2000 | 972 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2009 | 15110 | 0.020 |
Why?
|
| Adolescent | 2 | 2009 | 20987 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2014 | 232 | 0.020 |
Why?
|
| Female | 6 | 2019 | 70963 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 130 | 0.020 |
Why?
|
| 2,4-Dinitrophenol | 1 | 1992 | 3 | 0.020 |
Why?
|
| Dinitrophenols | 1 | 1992 | 5 | 0.020 |
Why?
|
| Puromycin | 1 | 1992 | 11 | 0.020 |
Why?
|
| Nocodazole | 1 | 1992 | 11 | 0.020 |
Why?
|
| Glucosamine | 1 | 1992 | 11 | 0.020 |
Why?
|
| Brefeldin A | 1 | 1992 | 11 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1992 | 40 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 1992 | 21 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 254 | 0.020 |
Why?
|
| Cosmids | 2 | 1988 | 38 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1995 | 398 | 0.020 |
Why?
|
| Tunicamycin | 1 | 1990 | 8 | 0.020 |
Why?
|
| Middle Aged | 2 | 2009 | 28601 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1988 | 73 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1990 | 167 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1990 | 89 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 1990 | 1046 | 0.020 |
Why?
|
| Biological Evolution | 2 | 1988 | 222 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1990 | 437 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1989 | 276 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4738 | 0.020 |
Why?
|
| Calcium | 1 | 1994 | 1010 | 0.020 |
Why?
|
| Glutamates | 1 | 1989 | 53 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1979 | 0.020 |
Why?
|
| Vitronectin | 1 | 2008 | 5 | 0.020 |
Why?
|
| Child | 1 | 2009 | 26341 | 0.020 |
Why?
|
| Lysine | 1 | 1989 | 167 | 0.020 |
Why?
|
| Cell Shape | 1 | 2008 | 67 | 0.020 |
Why?
|
| Fibronectins | 1 | 2008 | 99 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1989 | 190 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2002 | 1591 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1989 | 200 | 0.020 |
Why?
|
| Allosteric Site | 1 | 2007 | 12 | 0.020 |
Why?
|
| Biopolymers | 1 | 2007 | 17 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 295 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 61 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1988 | 95 | 0.020 |
Why?
|
| Antithrombins | 1 | 2007 | 49 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1986 | 94 | 0.010 |
Why?
|
| Ligands | 1 | 2007 | 481 | 0.010 |
Why?
|
| Plasmids | 1 | 1987 | 449 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1989 | 1207 | 0.010 |
Why?
|
| Heterozygote | 1 | 1987 | 737 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1064 | 0.010 |
Why?
|
| Species Specificity | 3 | 1989 | 470 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1986 | 776 | 0.010 |
Why?
|
| Alleles | 1 | 1988 | 1673 | 0.010 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2002 | 17 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1986 | 440 | 0.010 |
Why?
|
| Culture Media | 1 | 1983 | 171 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 2002 | 38 | 0.010 |
Why?
|
| Half-Life | 1 | 1982 | 149 | 0.010 |
Why?
|
| Genotype | 1 | 1988 | 2595 | 0.010 |
Why?
|
| Endocytosis | 1 | 1982 | 121 | 0.010 |
Why?
|
| Pregnancy | 2 | 1992 | 7512 | 0.010 |
Why?
|
| Hexosaminidases | 1 | 1981 | 6 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1982 | 808 | 0.010 |
Why?
|
| Amino Acid Transport Systems | 1 | 2000 | 9 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2000 | 20 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 55 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2000 | 25 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2000 | 22 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2000 | 43 | 0.010 |
Why?
|
| Kidney | 1 | 1987 | 1282 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 450 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 329 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 410 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 335 | 0.010 |
Why?
|
| Antibodies | 1 | 2000 | 322 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 1447 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2000 | 283 | 0.010 |
Why?
|
| Amino Acids | 1 | 2000 | 566 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 3061 | 0.010 |
Why?
|
| Biomarkers | 1 | 2000 | 3385 | 0.010 |
Why?
|
| Brain | 1 | 2002 | 3175 | 0.000 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 1989 | 5 | 0.000 |
Why?
|
| Necrosis | 1 | 1989 | 192 | 0.000 |
Why?
|
| Kidney Medulla | 1 | 1988 | 18 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 148 | 0.000 |
Why?
|
| Digestive System | 1 | 1988 | 58 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1989 | 201 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1988 | 394 | 0.000 |
Why?
|
| Pancreas | 1 | 1988 | 217 | 0.000 |
Why?
|
| Multigene Family | 1 | 1988 | 290 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1988 | 461 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1986 | 225 | 0.000 |
Why?
|
| Exons | 1 | 1988 | 759 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1987 | 556 | 0.000 |
Why?
|
| Pedigree | 1 | 1986 | 1677 | 0.000 |
Why?
|
| alpha-N-Acetylgalactosaminidase | 1 | 1981 | 1 | 0.000 |
Why?
|
| Galactosides | 1 | 1981 | 9 | 0.000 |
Why?
|
| Acetylgalactosamine | 1 | 1981 | 12 | 0.000 |
Why?
|
| Hymecromone | 1 | 1981 | 11 | 0.000 |
Why?
|
| Genetic Carrier Screening | 1 | 1981 | 67 | 0.000 |
Why?
|